Proposed Study Designs for Approval Based on a Surrogate Endpoint and a Post-Marketing Confirmatory Study Under FDA’s Accelerated Approval Regulations for Disease Modifying Osteoarthritis Drugs
Osteoarthritis and Cartilage - United Kingdom
doi 10.1016/j.joca.2018.11.002
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2019
Authors
Publisher
Elsevier BV